Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias

European Journal of Pharmacology

Volumn 388, Issue 2, 2000, Pages 171-176

  Naito, Hisaya ^a   Furukawa, Yasuyuki ^b   Chino, Daisuke ^a   Yamada, Chikaomi ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dog; Ischemia induced arrhythmia; Propranolol; Reperfusion arrhythmia; Zatebradine

Indexed keywords

PROPRANOLOL; ZATEBRADINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFICACY; FEMALE; HEART ATRIUM PACING; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARRHYTHMIA; BENZAZEPINES; BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; CARDIOTONIC AGENTS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; FEMALE; HEART RATE; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PROPRANOLOL;

EID: 0033956244     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00845-6     Document Type: Article

References (32)

1. Bernier M., Curtis M., Hearse D. Ischemia-induced and reperfusion-induced arrhythmias: importance of heart rate. Am. J. Physiol. 256:1989;H21-H31.
2. Bolli R., Fisher D., Entman M. Factors that determine the occurrence of arrhythmias during acute myocardial ischemia. Am. Heart J. 111:1986;261-270.
3. Bril A., Forest M., Cheval B., Landais L., Gout B. Effect of zatebradine, a specific bradycardic agent, on ischemia-induced arrhythmias in anesthetized rabbits. Pharmacology. 48:1994;308-319.
4. Carbonin P., DiGennaro M., Valle R., Weisz A. Inhibitory effect of anoxia on reperfusion-and digitalis-induced ventricular tachyarrhythmias. Am. J. Physiol. 240:1981;H730-H737.
5. Coetzee W.A., Dennis S.C., Opie L.H., Muller C.A. Calcium channel blockers and early ischemic ventricular arrhythmias: Electrophysiological versus anti-ischemic effects. J. Mol. Cell. Cardiol. 19(Suppl):1987;77-97.
6. Corr P., Shayman J., Kramer J., Kipnis R. Increased alpha-adrenergic receptors in ischemic cat myocardium. A potential mediator of electrophysiological derangements. J. Clin. Invest. 67:1981;1232-1236.
7. Curtis M.J., MacLeod B.A., Walker M.J.A. Antiarrhythmic actions of verapamil against ischemia arrhythmias in the rat. Br. J. Pharmacol. 83:1984;373-385.
8. Furukawa Y., Nakano T., Oguchi T., Kasama M., Hoyano Y., Chiba S. Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs. J. Pharmacol. Exp. Ther. 272:1995;744-749.
9. Furukawa Y., Xue Y.X., Chiba S., Hashimoto K. Effects of zatebradine on ouabain-, two-stage coronary ligation- and epinephrine-induced ventricular tachyarrhythmias. Eur. J. Pharmacol. 300:1996;203-210.
10. f in rabbit sinoatrial node cells by zatebradine. Circulation. 88:1993;2389-2401.
11. Guth B., Heusch G., Seitelberger R., Ross J. Jr. Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis. Circulation. 75:1987;661-669.
12. Hashimoto K., Haruno A., Matsuzaki T., Hirasawa A., Awaji T., Uemura Y. Effects of a new class III antiarrhythmic drug (E-4031)on canine ventricular arrhythmia models. Asia. Pacific. J. Pharmacol. 6:1991;127-137.
13. Hashimoto K., Haruno A., Hirasawa A., Awaji T., Xue Y.X., Wu Z.J. Effects of the new class III antiarrhythmic drug MS-551 and d-sotalol on canine coronary ligation-reperfusion ventricular arrhythmias. Jpn. J. Pharmacol. 68:1995;1-9.
14. Hashimoto K., Haruno A., Matsuzaki T., Sugiyama A., Akiyama K. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness? Cardiovasc. Drug. Ther. 5:1991;805-818.
15. Irisawa H., Brown H.F., Giles W. Cardiac pacemaking in the sinoatrial node. Physiol. Rev. 73:1993;197-227.
16. Janse M.J., Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 69:1989;1049-1169.
17. Kabeli G., Scherlag B.J., Hope R.R., Lazzara R. Regional myocardial blood flow and ventricular arrhythmias following one-stage and two-stage coronary artery occlusion in anesthetized dogs. Am. Heart J. 104:1982;537-545.
18. Kaplinsky E., Ogawa S., Balke W., Breifus L.S. Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model. Circulation. 60:1979;397-403.
19. Kobinger W., Lillie C. Cardiovascular characterization of UL-FS 49,1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent" Eur. J. Pharmacol. 104:1984;9-18.
20. Naito M., Michelson E., Kmetzo J.J., Kaplinsky E., Dreifus L.S. Failure of antiarrhythmic drug to prevent experimental reperfusion ventricular fibrillation. Circulation. 63:1981;70-79.
21. O'Brien P., Drage D., Saeian K., Brooks H., Warltier D. Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agent. Am. Heart. J. 123:1992;566-574.
22. Penny W.J. The deleterious effects of myocardial catecholamines on cellular electrophysiology and arrhythmias during ischaemia and reperfusion. Eur. Heart. J. 5:1984;960-973.
23. Pogwizd S., Corr B. Reentrant and nonreentrant mechanisms contribute to arrhythmogenesis during early myocardial ischemia: Results using three-dimensional mapping. Circ. Res. 61:1987;352-371.
24. Sawaki S., Furukawa Y., Inoue Y., Oguchi T., Chiba S. Zatebradine attenuates cyclic AMP-related positive chronotropic but not inotropic responses in isolated, perfused right atria of the dog. Clin. Exp. Pharmacol. Physiol. 22:1995;29-34.
25. Schoemig A., Dart A.M., Dietz R., Mayer E., Kuebler W. Release of endogenous catecholamines in the ischemic myocardium of the cat. Part A: locally mediated release. Circ. Res. 55:1984;689-701.
26. Thollon C., Cambarrat C., Vian J., Prost J.F., Peglion J.L., Vilaine J.P. Electrophysiological effects of S 16257, a novel sinoatrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br. J. Pharmacol. 112:1994;37-42.
27. Tosaki A., Szekeres L., Hearse D. Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia. J. Cardiovasc. Pharmacol. 10:1987;489-497.
28. Van Bogaert P.P., Goethals M. Pharmacological influence of specific bradycardic agents on the pacemaker current of sheep Purkinje fibers. A comparison between three different molecules. Eur. Heart. J. Suppl. 8:1987;35-42.
29. Wainwright C.L., Parratt J.R. Effects of R-PIA, aselective A1 adenosine agonist, on haemodynamics and ischemic arrhythmias in pigs. Cardiovasc. Res. 27:1993;84-89.
30. + exchange inhibitor, on ventricular arrhythmias in animal hearts. Eur. J. Pharmacol. 317:1996;309-316.
31. Xue Y.X., Eto K., Akie Y., Hashimoto K. Antiarrhythmic and Proarrhythmic effects of sematilide in canine ventricular arrhythmia models. Jpn. J. Pharmacol. 70:1996;129-138.
32. Yu H., Chang F., Cohen I.S. Pacemaker current exists in ventricular myocyte. Circ. Res. 72:1993;232-236.